Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Oculis Publishes Notification of Transaction by Person Discharging Managerial…
Attachment Notification of managers' transaction - Arshad Khanani - Nov 2024
Nasdaq GlobeNewswire
27/11/2024
Immunovia Publishes Interim Report for January-September 2024
Significant events after the period Significant events after the period CEO's comments ON PLAN FOR A US MARKET INTRODUCTION IN 2025 Q3 marked another quarter of strong performance as we continued to achieve our goals and deliver on milestones. As previously reported, the analytical validation proved our next-generation test to be accurate, stable and precise. The test development will culminate with the clinical validation, which will read out in Q4. Looking ahead to 2025, we...
PR Newswire
27/11/2024
Global initiative launched to train scientists to safely test cosmetics…
A result of wide-ranging contributions from global experts in animal-free safety science, the AFSA Master Class aims to provide the educational building blocks for lasting change, encouraging kinder scientific practices that will also better ensure human safety. Regulators, product developers, contract research organizations, and academic professionals from across the globe are all active in development of the course, illustrating the truly collaborative nature of animal-free safety science…
PR Newswire
27/11/2024
142,701 Orion Corporation A shares converted into B shares
ORION CORPORATIONSTOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 27 NOVEMBER 2024 at 9.00 EET 142,701 Orion Corporation A shares converted into B shares In accordance with Section 3 of the Articles of Association of Orion Corporation, 142,701 A shares have been converted into 142,701 B shares. The conversion has been entered into the Trade Register on 27 November 2024.The total number of shares in Orion Corporation is...
Nasdaq GlobeNewswire
27/11/2024
Novartis Kisqali® receives European Commission approval in a broad population of…
Approval is based on Phase III NATALEE data showing Kisqali ®(ribociclib) plus adjuvant endocrine therapy (ET) demonstrated clinically meaningful invasive disease-free survival (iDFS) benefit in patients with stage II or III HR+/HER2- early breast cancer (EBC), consistent across all subgroups 1,2 With this broad indication, nearly twice as many EBC patients in Europe, including those with node-negative disease, could now be eligible for treatment with Kisqali to help reduce...
Nasdaq GlobeNewswire
27/11/2024
Idorsia enters into exclusive negotiations for global rights to aprocitentan
Ad hoc announcement pursuant to Art. 53 LR Company enters into exclusive negotiations with an undisclosed party for global rights to aprocitentanCompany to streamline the business, resulting in cost containment – consequently, approximately 270 positions globally could become redundantCompany plans to restructure its outstanding debtAllschwil, Switzerland – November 27, 2024Idorsia Ltd (SIX: IDIA) today announced that it has entered into exclusive negotiations with an undisclosed...
Nasdaq GlobeNewswire
27/11/2024
Press Release: Publication in Kidney Medicine Highlights Benefits of DSR 2.0 for…
Publication in Kidney MedicineHighlights Benefits of DSR 2.0 for Sequana Medical's Direct Sodium Removal Heart Failure Program and Board Composition Update More efficient sodium and fluid removal, and improved safety versus dextrose-based approachesBoard changes to improve efficiency and meet gender diversity requirements Ghent, Belgium – 27 November 2024– Sequana Medical NV (Euronext Brussels: SEQUA)(the " Company " or " SequanaMedical "), a pioneer in the...
Nasdaq GlobeNewswire
27/11/2024
Taiwan's Products for Modern Households Focus on Customization, Health, and…
Or email:
[email protected]
Or email:
[email protected]
Mattresses customizable to modern sleepers As the world increasingly prioritizes mental health, sleep quality, which is crucial to managing stress and promoting wellbeing, has also come into focus. Accordingto the Sleep Foundation, 46% of people with below-average sleep consider their mental health as 'poor'. The right mattress can make all the difference, particularly a mattress specially...
PR Newswire
27/11/2024
Tineco Recognized as Global Leader in Emerging Floor Washer Category
Harnessing more than two decades of industry innovation, Tineco began its journey with a single vacuum cleaner. Pioneering industry excellence, a notable moment in company history was the launch of the first-ever smart vacuum to market in 2018, quickly followed by an inaugural smart floor washer in 2019, and an intelligent carpet cleaner in 2022. Today, Tineco products are enjoyed by 14 million users across key markets worldwide, including regions in North America, Europe, and Asia…
PR Newswire
27/11/2024
Down's Syndrome Market to Exhibit Growth at a CAGR of 3.81% by 2034 |…
Key Takeaways from the Down's Syndrome Market Report Key Takeaways from the Down's Syndrome Market Report Discover which therapies are expected to grab the major Down's syndrome market share @ Down's Syndrome Market Report Down's Syndrome Overview Down's syndrome, also known as trisomy 21, is a genetic disorder caused by the presence of an extra copy of chromosome 21. This chromosomal anomaly disrupts normal development, resulting in a range of physical and cognitive...
PR Newswire
26/11/2024
Innocan Pharma Announces Encouraging Results from a Safety Assessment Study of…
Minipigs are breeds of miniature domestic pigs which are recognized by the FDA as a robust translational model due to their anatomical, physiological, and biochemical similarities to humans. They provide valuable insights into pharmacokinetics, toxicity, and drug efficacy. Minipigs are breeds of miniature domestic pigs which are recognized by the FDA as a robust translational model due to their anatomical, physiological, and biochemical similarities to humans. They provide valuable insights...
PR Newswire
26/11/2024
Disclosure of notification received from FMR LLC
Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 26 November 2024 – 6.45 PM CET Disclosure of notification received from FMR LLC Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major shareholdings in listed companies, Fagron received a notification from FMR LLC. Notification by FMR LLCOn 21 November 2024, Fagron received a notification that the shareholding of Fidelity Management & Research Company LLC, a controlled undertaking of FMR...
Nasdaq GlobeNewswire
26/11/2024
UroMems Appoints Former Axonics Executive Rinda Sama to Board of Directors
"We are thrilled to welcome Rinda to our board of directors," said UroMems co-founder and CEO Hamid Lamraoui. "Rinda's deep experience in medical technology, and specifically with the Axonics sacral neuromodulation (SNM) therapy to treat overactive bladder, will be invaluable to UroMems as we embark on large-scale U.S. and European pivotal clinical trials of UroActive®, in preparation for the commercial launch of the first smart automated artificial urinary sphincter (AUS) to…
PR Newswire
26/11/2024
Valneva Submits Label Extension Application for its Chikungunya Vaccine…
To potentially include adolescents and antibody persistence up to two yearsSaint Herblain (France), November 26, 2024–Valneva SE(Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it has submitted a label extension application to the U.S. Food and Drug Administration (FDA) to potentially extend the use of its chikungunya vaccine IXCHIQ ®, which is currently approved in adults, to adolescents aged 12 to 17 years. The application also includes...
Nasdaq GlobeNewswire
26/11/2024
How CROs Are Transforming Global Research and Development
This report looks at the global market for CRO services, covering the major companies in the sector. It explains the clinical trial process, including the different phases and services CROs provide, and highlights the therapeutic areas they work in, such as cancer, heart disease and neurology. This report looks at the global market for CRO services, covering the major companies in the sector. It explains the clinical trial process, including the different phases and services CROs provide, and...
PR Newswire
26/11/2024
Surgical Staplers Market to Hit USD 7.29 Billion by 2029 with 7.2% CAGR |…
Browse in-depth TOC on "Surgical Staplers Market"280 - Tables60 - Figures300 - Pages Browse in-depth TOC on "Surgical Staplers Market" 280 - Tables 60 - Figures 300 - Pages The surgical stapler's market is segmented into linear surgical staplers, circular surgical staplers, skin surgical staplers, and other surgical staplers based on type. Linear surgical staplers accounted for the largest share of global surgical staplers' market. Linear staplers, in gastrointestinal…
PR Newswire
26/11/2024
Muscle Relaxant Drugs Market is expected to generate a revenue of USD 6.59…
As the demand for effective muscle relaxants continues to grow, driven by rising cases of musculoskeletal disorders, increased surgical procedures, and advancements in drug formulations, the Muscle Relaxant Drugs Market is witnessing substantial growth. With a focus on data-backed trends, emerging opportunities, and future projections, our upcoming report will serve as a definitive guide for stakeholders who seek to stay ahead in this dynamic market. As the demand for effective muscle…
PR Newswire
26/11/2024
VectorBuilder and Sartorius Sign Strategic Cooperation Agreement to Advance…
"Sartorius is deeply committed to customer-centric innovation, which is the cornerstone of our product development and service provision," said Sarah Wang, Head of Sartorius China. "We anticipate that this strategic partnership will yield innovative solutions aimed at enhancing the efficiency and quality of biomedical enterprises. Together, we aim to support the growth of our global customers and the broader biomedical industry, and to contribute to the advancement of life…
PR Newswire
26/11/2024
PHARMANUTRA S.P.A.: DISTRIBUTION AGREEMENT FOR SIDERAL® PRODUCTS SIGNED IN…
The contract has been signed with the Canadian pharmaceutical company Sigma Lifesciences, which is active in the production and distribution of health products, for the sale of four products in Canada, adding to the over 80 countries where the company founded in 2003 by Andrea and Roberto Lacorte is already present. The contract has been signed with the Canadian pharmaceutical company Sigma Lifesciences, which is active in the production and distribution of health products, for the sale of…
PR Newswire
26/11/2024
Bridging Global Businesses: Overseas Buyers Discover More Opportunities at the…
Managing Sonae's Guangzhou office, Duarte plays a pivotal role in the company's commercial and sourcing activities in China and Asia. He noted that Chinese products have made positive impressions among consumers in Portugal for high-cost performance and quality. Having joined the three phases of the 136th Canton Fair, Duarte and his colleagues not only discovered a wide range of innovative new products but also identified numerous excellent suppliers. Managing Sonae'sGuangzhouoffice, Duarte...
PR Newswire
26/11/2024
Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase HER2-low…
"Following the results of the DESTINY-BREAST04 trial at the American Society of Clinical Oncology meeting in 2022, HER2-low emerged as an important biomarker within metastatic breast cancer (mBC)," said Maya R. Said, Sc.D., Founder and CEO of Outcomes4Me. "We knew that many patients living with mBC would benefit from understanding their HER2-low status. We recognize the need to translate the latest clinical research into clinical practice in a timely manner, however, studies have…
PR Newswire
26/11/2024
OKYO Pharma to Participate at the 4th Annual BTIG Ophthalmology Conference
LONDON and NEW YORK, Nov.26, 2024(GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP), a severe ocular condition without an FDA approved therapy, and for inflammatory dry eye disease (DED), a multi-billion-dollar market, is pleased to announce that its CEO, Gary S. Jacob, Ph.D., will be participating in one on one meetings and a fireside chat at the 4 th Annual...
Nasdaq GlobeNewswire
26/11/2024
iTeos to Participate in Upcoming Investor Conferences
7 ThAnnual Evercore HealthCONx ConferenceFormat: Fireside chat and one-on-one investor meetings Date: Tuesday, December 3, 2024 Time: 9:35 AM ET Location: Coral Gables, FL Piper Sandler 36 thAnnual Healthcare ConferenceFormat: Fireside chat and one-on-one investor meetings Date: Wednesday, December 4, 2024 Time: 11:30 AM ET Location: New York, NYA live webcast of the conference presentation will be available on the Investors section of the company's website atwww...
Nasdaq GlobeNewswire
26/11/2024
Dietary Supplements Market worth $258.75 billion by 2029 - Exclusive Report by…
The growing awareness of wellness and health issues has been a key factor driving the increase in demand for vegan supplements. Consumers are becoming more aware of the impact their dietary habits have on their well-being in general. This awareness has now brought with it a high demand for supplements that are healthy nutrition enhancers, energy creators, and immunity boosters, which align with plant-based standards. For example, people using a vegan diet can face difficulties in meeting their…
PR Newswire
26/11/2024
Altri Comunicati